Peptides
Prostamax
Also called Prostamax
People explore Prostamax for easier urination, fewer nighttime bathroom trips and prostate comfort. Those symptoms matter, but they do not identify the cause by themselves. The peptide’s tissue and animal research does not establish relief of human urinary symptoms or a way to shrink an enlarged prostate.
Dosage & duration
One public self-report, not a validated prostate regimen
One reported use
Reported use · unapproved regimen- Dose
- 750 mcg per morning dose
- How often
- Once daily; route not clearly specified in the report
- How long
- About 3 weeks
The author had not confirmed an enlarged prostate by testing. This is not a common-use range or evidence of disease treatment.
Do not infer an SC route or repeat-cycle interval from this account. Inability to urinate needs urgent medical care.
Why people consider Prostamax
Fewer bathroom trips, easier urination
-
Less interrupted sleep
The hope is fewer nighttime trips to the bathroom.
-
Easier emptying
Readers hope for better flow and less feeling that the bladder is still full.
-
More comfort
Pain and urgency are other reasons people look for prostate support.
Why do people look at Prostamax?
Frequent urination, interrupted sleep and discomfort can be frustrating. The promise of prostate-specific support sounds direct, but similar symptoms can arise from different conditions. An online response story cannot identify the cause of yours.
What did the research test?
The reviewed studies used rat tissue or experimental inflammation in rats. They are not trials showing better urinary flow or reduced prostate size in people. Treating a laboratory inflammation model is also not the same as treating a bacterial infection.
Be careful with the name
Prostamax-like names appear on herbal supplements, tissue extracts and synthetic peptides. Those products can have entirely different ingredients. A dose or result for one should not be copied to another.
What makes a useful next step?
Describe the symptom pattern and get persistent or worsening changes assessed. A normal-looking plot or less discomfort does not rule out a significant prostate problem. An abnormal PSA result needs clinical interpretation, not an attempt to normalize it with a peptide.
Model details: Prostamax · relative timing
Compare timing and buildup for this compound. The values are not blood concentrations or a measure of strength.
Shows a relative timing scenario; absolute blood concentrations are not calibrated.
Timing assumptions and sources
Legacy 4.08 h is an assumed timescale; the 0.05 ng/mL tissue-culture concentration is not a plasma peak.
One 1 mg input peaks at 1 relative unit after a single dose. Other amounts scale proportionally; overlapping doses add when accumulation is on. Different compounds use separate relative scales.
- Timing half-life used
- 4.08 hours
- Absorption half-life assumed
- 1.02 hours
- Reference amount for the relative scale
- 1 mg
- Absorption half-life is assumed to be one quarter of the slower timescale (1.02 h); it is not a measured absorption parameter.
- A single 1-unit input has a peak of 1 relative unit; scaling and repeated-dose addition are mathematical assumptions. This normalization is independent of the example dose.
- Do not mistake cultured human donor cells for an administered-human study.
- No route-matched human PK established in reviewed sources.
- [The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats].
Legacy 4.08 h is an assumed timescale; the 0.05 ng/mL tissue-culture concentration is not a plasma peak.
prostamax-relative-timing-2026-10 · version 1
Common questions
Can Prostamax shrink an enlarged prostate?
That outcome is not established by the cited rat and tissue studies. Symptom improvement alone would not prove shrinkage.
Is it the same as Prostatilen or a prostate herbal capsule?
No equivalence follows from a similar name. Check the actual active ingredients and formulation; their doses and evidence are not interchangeable.
Sources Labels, studies and notes behind this guide
Catalog evidence: Animal or laboratory research. This describes the type of evidence, not a clinical review of every claim.
Summary and fact source checks: 2026-10-07. This records source checking, not medical review of the whole page.
Notes on the quick facts
- Main goals
- Night waking and a weak stream need a diagnosis, not an assumed peptide deficiency.
- Evidence gap
- Rat tissue findings do not establish a smaller human prostate.
- Product names
- Herbal products and animal extracts can share similar names.
- 1. Zakutskii et al.: prostate tissue cultures
Original abstract inspected: rat organotypic explants; not human urinary outcomes.
- 2. Prostamax rat prostatitis experiment, 2013
Full original paper inspected: surgically induced aseptic prostatitis in rats; not diagnosed BPH or human infection.
- 3. [The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats].
Legacy 4.08 h is an assumed timescale; the 0.05 ng/mL tissue-culture concentration is not a plasma peak.
- 4. Prostamax chromatin experiment, 2012
Lys-Glu-Asp-Pro and chromosome measures in cells from older people; no treated-patient prostate endpoint.
Keep reading
Related compounds and examples
Related compounds
Testagen
Testagen for testosterone and vitality questions: reported amounts, libido versus blood tests and why the peptide is not established TRT or fertility treatment.
Pinealon
Pinealon for memory and brain-aging questions: capsule versus injection amounts, realistic expectations and what its research actually measures.
Epithalon (Epitalon)
Epithalon for sleep and longevity: reported dose ranges, Epithalamin confusion and why telomere changes do not prove longer life.